Peak6 Investments LLC Altimmune, Inc. Call Options Transaction History

Peak6 Investments LLC

  • $37.5 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 12, 2023
BUY
$4.19 - $16.83 $80,029 - $321,452
19,100 New
19,100 $80,000
Q3 2022

Nov 14, 2022
BUY
$10.67 - $22.41 $926,156 - $1.95 Million
86,800 New
86,800 $1.11 Million
Q3 2021

Nov 12, 2021
SELL
$8.43 - $16.81 $421,500 - $840,499
-50,000 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$9.85 - $16.46 $492,500 - $823,000
50,000 New
50,000 $492,000

Others Institutions Holding ALT

# of Institutions
190
Shares Held
42M
Call Options Held
1.05M
Put Options Held
582K
View Full List

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $377M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email